Aspire Biopharma Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
Holders of 5% or more of ASBP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aspire Biopharma Holdings, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Friedman Lance | 13G/A | 7.92%107.3K shares | +3.40 ppfrom 4.52% | Feb 26, 202511 filings | Aug 6, 2026 | SEC |
| Shirinyan Gary | 13G | 7.70%99.9K shares | New | Aug 10, 20261 filing | Aug 10, 2026 | SEC |
| Rubenbauer Alois Ryan III | 13G | 5.00%65.0K shares | New | Jul 2, 20261 filing | Jul 2, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
22 Schedule 13D and 13G filings on Aspire Biopharma Holdings, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202612:30 PM ET | Highbridge Capital Management LLC | 13G/A | 0.00%78 shares | −5.20 ppfrom 5.20%Below 5% | Jun 30, 2026 | SEC |
| Aug 10, 20268:30 PM ET | Shirinyan Gary | 13G | 7.70%99.9K shares | New | Jun 17, 2026 | SEC |
| Aug 6, 20268:47 PM ET | Friedman Lance | 13G/A | 7.92%107.3K shares | +3.40 ppfrom 4.52% | Aug 4, 2026 | SEC |
| Jul 2, 20268:38 AM ET | Rubenbauer Alois Ryan III | 13G | 5.00%65.0K shares | New | Jun 25, 2026 | SEC |
| May 15, 20266:44 AM ET | Highbridge Capital Management LLC | 13G | 5.20%273.0K shares | New | Mar 31, 2026 | SEC |
| May 13, 20261:00 PM ET | Ardsley Advisory Partners LPand 5 others | 13G/A | 0.00%0 shares | −7.76 ppfrom 7.76%Below 5% | Dec 31, 2025 | SEC |
| Feb 12, 20261:00 PM ET | Ardsley Advisory Partners LPand 5 others | 13G | 7.76%10.8M shares | New | Dec 31, 2025 | SEC |
| May 19, 20258:30 PM ET | Friedman Lance | 13G/A | 4.52%2.21M shares | −3.40 ppfrom 7.92%Below 5% | May 6, 2025 | SEC |
| May 15, 202512:14 PM ET | Harraden Circle Investments, LLCand 6 others | 13G/A | 0.31%150.0K shares | –Below 5% | Mar 31, 2025 | SEC |
| May 7, 20255:15 PM ET | Friedman Lance | 13G/A | 7.92%3.87M shares | −0.33 ppfrom 8.25% | Apr 29, 2025 | SEC |
| Apr 23, 20257:48 PM ET | Friedman Lance | 13G/A | 8.25%4.04M shares | −0.03 ppfrom 8.28% | Apr 21, 2025 | SEC |
| Apr 17, 20254:22 PM ET | Friedman Lance | 13G/A | 8.28%4.05M shares | −0.27 ppfrom 8.55% | Apr 11, 2025 | SEC |
| Apr 11, 20254:55 PM ET | Friedman Lance | 13G/A | 8.55%4.18M shares | −0.43 ppfrom 8.98% | Apr 4, 2025 | SEC |
| Apr 4, 20255:28 PM ET | Friedman Lance | 13G/A | 8.98%4.39M shares | −0.10 ppfrom 9.08% | Mar 26, 2025 | SEC |
| Mar 28, 20255:29 PM ET | Friedman Lance | 13G/A | 9.08%4.44M shares | −0.38 ppfrom 9.46% | Mar 19, 2025 | SEC |
| Mar 20, 20259:58 PM ET | Friedman Lance | 13G/A | 9.46%4.61M shares | −0.36 ppfrom 9.82% | Mar 3, 2025 | SEC |
| Mar 12, 20254:05 PM ET | Friedman Lance | 13G/A | 9.82%4.80M shares | −0.16 ppfrom 9.98% | Mar 3, 2025 | SEC |
| Feb 26, 20259:20 PM ET | Friedman Lance | 13G | 9.98%4.88M shares | New | Feb 17, 2025 | SEC |
| Mar 7, 2022 | Adage Capital Partners GP, L.L.C. | 13GOld format | – | New | – | SEC |
| Feb 28, 2022 | Millennium Management LLC | 13GOld format | – | New | – | SEC |
| Feb 28, 2022 | Linden Capital L.P. | 13GOld format | – | New | – | SEC |
| Feb 28, 2022 | Saba Capital Management, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aspire Biopharma Holdings, Inc. shares.
No Form 144 notices for Aspire Biopharma Holdings, Inc. are on file.